About us- new updates

ABOUT US

A game changer in
healthcare

Our Company

We are a team of passionate life sciences, cybersecurity and digital innovation experts.

OUR MISSION:

Hyper-accelerate drug and medical device development through in silico trials executed on our platform.

OUR VISION:

Boost the world’s transition to accessible therapies.

0
Research Collaborations
0
Products

Meet the team

1N5A3457

ALESSIA BARETTA

Sr. Product Manager MedTech

MARC ANTONIO BISOTTI

Software Engineer

1N5A3733

DANIELE BORLIZZI

Strategy & Business Development

roberta_Bursi_4

ROBERTA BURSI

Co-Founder & Exec. VP of R&D

1N5A3545

VINCENZO CARBONE

Sr. Product Manager MedTech

1N5A3362 (1)

NICOLETA DOROFTEI

Digital Marketing Specialist

Luca Emili_4

LUCA EMILI 

Founder and CEO

1N5A3291 (1)

MATTEO GAZZIN

Engineering Manager

NISSRINE HNAINIA

Web Developer

1N5A3374

CHIARA NICOLO

Pharmacometrician

ALBERTO PALAZZIN

Technical Lead

1N5A3409

FIANNE SIPS

Pharmacometrician

1N5A3661

DORINA STANCULESCU

Head of PR & Communication

1N5A3631

MARIO TORCHIA

VP of Sales & Marketing

1N5A3472

CRISTINA VAGHI

Pharmacometrician

1N5A3339-Modifica (1)

AMY WRIGHT

Business Development Manager

Sustainability goals

As one of our main objectives is to hyper-accelerate innovation in the Pharma and MedTech industry, we are addressing several sustainable development goals (SDGs).

In particular, we are actively involved with the third SDG – Good Health and Well-being (Ensure healthy lives and promote well-being for all at all ages) with a specific focus on target 3.B – support research, development, and universal access to affordable vaccines and medicines. Our technology allows for significant cost and time savings in drug development, which results in faster-to- market medicines and medical devices.

Another goal we actively tackle is SDG 9 – Industry, Innovation, and Infrastructure (Build resilient infrastructure, promote inclusive and sustainable industrialization, and foster innovation) with a specific focus on target 9.5 – enhance research and upgrade industrial technologies.

With our platform, we want to make in silico trials more accessible to all Pharma and medical devices companies – even to SMEs and emerging BioTechs that usually don’t have the same competitive budget as established Big Pharma to perform clinical trials.

We are also committed to a long-term goal: the reduction and replacement  of animals in research since in silico trials can be used as substitutes for in vivo testing.

Our investors

Diversity & Inclusion

InSilicoTrials is an Equal Opportunity Employer. All our employees have been and will be selected without regard to race, color, age, religion, sex, sexual orientation, gender identity /expression and national origin. As a company with 16 employees representing 6 different nationalities, InSilicoTrials is committed to foster and deliver innovation through a diverse workforce and a fast-paced inclusive environment.

Gender diversity is central to our inclusion policies. In fact, gender representation criteria are integrated into our hiring metrics allowing 50% of female employees within our team with equal and competitive remuneration plans.

Start simulating now